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Introduction
The developing foetus, in response to changes in the
in utero environment develops compensatory strategies to
overcome insults that they experience. Such compensa-
tions could be adaptive, if they support survival, or
disruptive, if they compromise postnatal survival. ‘Devel-
opmental plasticity’, the ability of the developing foetus
to change structure ⁄ function in response to physiological
cues from the mother, underlies the developmental origin
of disease or Barker hypothesis (Barker, 1994). The
increased prevalence of some common diseases may be
related to exposure during development to environmental
pollutants, lifestyle choices of the mother and medical
interventions, all of which can adversely influence devel-
opmental trajectory of target tissue differentiation. This
review addresses the reproductive and metabolic disrup-
tions resulting from exposure to excess native steroids
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Summary
The inappropriate programming of developing organ systems by exposure to
excess native or environmental steroids, particularly the contamination of our
environment and our food sources with synthetic endocrine disrupting chemi-
cals that can interact with steroid receptors, is a major concern. Studies with
native steroids have found that in utero exposure of sheep to excess testoster-
one, an oestrogen precursor, results in low birth weight offspring and leads to
an array of adult reproductive ⁄ metabolic deficits manifested as cycle defects,
functional hyperandrogenism, neuroendocrine ⁄ ovarian defects, insulin resis-
tance and hypertension. Furthermore, the severity of reproductive dysfunction
is amplified by excess postnatal weight gain. The constellation of adult repro-
ductive and metabolic dysfunction in prenatal testosterone-treated sheep is
similar to features seen in women with polycystic ovary syndrome. Prenatal
dihydrotestosterone treatment failed to result in similar phenotype suggesting
that many effects of prenatal testosterone excess are likely facilitated via aroma-
tization to oestradiol. Similarly, exposure to environmental steroid imposters
such as bisphenol A (BPA) and methoxychlor (MXC) from days 30 to 90 of
gestation had long-term but differential effects. Exposure of sheep to BPA,
which resulted in maternal levels of 30–50 ng ⁄ mL BPA, culminated in low
birth weight offspring. These female offspring were hypergonadotropic during
early postnatal life and characterized by severely dampened preovulatory LH
surges. Prenatal MXC-treated females had normal birth weight and manifested
delayed but normal amplitude LH surges. Importantly, the effects of BPA were
evident at levels, which approximated twice the highest levels found in human
maternal circulation of industrialized nations. These findings provide evidence
in support of developmental origin of adult reproductive and metabolic
diseases and highlight the risk posed by exposure to environmental endocrine
disrupting chemicals.
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and environmental steroid receptor modulators with spe-
cific focus on those that signal through oestrogen and
androgen receptors.
Developmental programming of reproductive/
metabolic dysfunction with native steroids
Steroid hormones play a major role during development
in setting the trajectory of developing organ systems.
Because, differentiation of organ systems depend upon
precise exposure to steroid hormones at specific times
during development, exposure to low doses of endocrine
disrupting compounds (EDCs) that can signal through
steroid receptors during these hormone sensitive, critical
periods of development can lead to long-term deleterious
effects on the adult organism. It is well established that
inappropriate exposure to excess testosterone (T) during
foetal life leads to phenotypic virilization and behaviour-
al masculinization in the female offspring (Jost et al.,
1973; Gorski, 1986; Wood & Foster, 1998). The amount
as well as the timing of T exposure dictates the degree
of masculinization of external genitalia in the female
(Wood & Foster, 1998). Inappropriate perinatal exposure
to excess T during early development also disrupts
reproductive cyclicity in several species (Abbott et al.,
2006).
For the remainder of the review, focus is on the repro-
ductive and metabolic disruptions resulting from inap-
propriate developmental exposure of sheep to native
steroids or environmental steroid mimics. Sheep are
exceptionally well suited for investigating developmental
programming of adult disorders. They have long been
used as model systems to study foetal physiology
(Harding & Bloomfield, 2004). Their developmental time
line (gestation length: 147 days, puberty in female:
approximately 28 weeks) is ideally suited for integrative
studies that address progression of reproductive ⁄ meta-
bolic disruption from the initial developmental insult to
manifestation of adult consequences, especially those that
involve detailed hormonal profiling or sequential moni-
toring of ovarian follicular dynamics. Importantly, they
can be studied in natural social settings thus reducing the
level of stress. From a reproductive perspective, ovarian
differentiation in sheep is similar to humans with full
follicular differentiation occurring by birth (Fig. 1A)
(Padmanabhan et al., 2007). Neuroendocrine aspects
of reproductive cyclicity are also similar to human
(McNeilly, 1991; Goodman & Inskeep, 2006).
Comparison of sheep treated with T (aromatizable
androgen) from days 30 to 90 of gestation (T30–90
females) with those treated from days 60 to 90 of gesta-
tion (T60–90 females) has helped address critical period
of programming of reproductive and metabolic disrup-
tions. Comparison of prenatal T, prenatal dihydrotestos-
terone (non-aromatizable androgen, DHT) and T plus
flutamide (an androgen antagonist) treatments has helped
address the quality of steroid (androgen or oestrogen)
responsible for programming adult dysfunctions (Fig. 1B).
Earlier studies with the Dorset breed of sheep found that
T30–90 females showed progressive deterioration of
cyclicity culminating in absent cycles during the second
breeding season (Fig. 2A) (Birch et al., 2003). Studies
with other breeds of sheep also found progressive loss of
cyclicity (Clarke et al., 1977; Manikkam et al., 2006), the
severity of which differing between breeds. In contrast,
majority of the T60–90 females cycled during the second








Development of hypophyseal portal vasculature
FSH in pituitary
Ovary clearly distinguishable with mitotically active oogonia






Appearance of FSH R & antral F
Primordial follicle differentiation complete
Appearance of primary F
Birth (full complement of F)
Days of gestation
0 30 60 90 147
30–90 vs. 60–90: Critical period
Gestation day
0 147753014 50 11055 1359040 100
T/DHT/T + Flutamide: Quality of steroid
(androgenic vs. estrogenic)
BPA/MXC: Environmental endocrine disruptors
Figure 1 (A) Schematic showing the time of appearance of different classes of follicles (F) in sheep, timing of establishment of hypophyseal por-
tal vasculature to pituitary and timing of appearance of LH and FSH in circulation and pituitary during foetal life in sheep. (B) Schematic showing
the timing and duration of the various steroid ⁄ EDC treatments used in studies discussed in this review.
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Comparison of cycle dynamics of T30–90 and DHT30–
90 females during the oestrous cycle found that T30–90
females were characterized by increased pre-ovulatory lev-
els of oestradiol, as well as delayed and severely damp-
ened LH surges (Fig. 2B) (Veiga-Lopez et al., 2009).
Detailed characterization of circulating LH dynamics dur-
ing the follicular phase found that T30–90 and T60–90
females were characterized by excess LH release
(Savabieasfahani et al., 2005; Manikkam et al., 2008).
Studies testing the fertility status of T60–90 females found
that 100% of the T60–90 females [T30–90 females are
phenotypically virilized and natural mating is not possible
(Wood & Foster, 1998)] were mated by the ram. How-
ever, fecundity was reduced with only 40% of those
mated becoming pregnant as opposed to the 90% preg-
nancy rate in the control herd (Fig. 2C) (Steckler et al.,
2007b). Even more importantly, recent studies found that
excess postnatal weight gain amplifies the reproductive







































































































Figure 2 (A) Plasma progesterone profiles
from representative control, T60–90, and
T30–90 females during the first and second
breeding seasons are shown on the left. On
the right are shown percentages of sheep
cycling during the first and second breeding
seasons (modified from Birch et al., 2003).
(B) Patterns of LH (closed circles) and
oestradiol (E) (open circles) from control (top),
T30–90 (middle), and DHT30–90 (bottom)
following oestrous synchronization with PGF2a
(Veiga-Lopez et al., 2009). (C) Percentage of
T60–90 females mated and becoming
pregnant following oestrous synchronization.
Estrus was synchronized with two injections
of PGF2a administered 11 days apart. Mating
was determined by heavy rump markings left
by a fertility-proven raddled ram (modified
from Steckler et al., 2007b).
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disruptions in T30–90 females (Fig. 3A) (Steckler et al.,
2009). These findings are supportive of the two-step pro-
cess (Tang et al., 2008), the first involving early life epige-
netic reprogramming of susceptible organ systems and a
later event influencing the severity of the pathologic phe-
notype (Fig. 3B).
Neuroendocrine disruptions
At the neuroendocrine level, prenatal T treatment reduces
hypothalamic sensitivity to all three major feedback sys-
tems involved in the control of cyclic changes in
GnRH ⁄ gonadotropin secretion; oestradiol (E) negative
feedback (Wood & Foster, 1998; Sarma et al., 2005), E
positive feedback (Wood & Foster, 1998; Sharma et al.,
2002; Unsworth et al., 2005) and progesterone negative
feedback (Robinson et al., 1999; Veiga-Lopez et al., 2009)
(Fig. 4). Further investigations have pointed to disrup-
tions of E negative feedback being programmed by andro-
genic action of T, with both, T and DHT and not
T + flutamide reducing sensitivity to E (Wood & Foster,
1998; Jackson et al., 2008; Veiga-Lopez et al., 2009).
E positive feedback disruptions were found in T30–90 but
not DHT30–90 females suggesting that this disruption is
likely programmed via oestrogenic actions of prenatal T
(Wood & Foster, 1998; Veiga-Lopez et al., 2009). Studies
testing pituitary sensitivity also found that both T30–90
and DHT30–90 females have enhanced sensitivity to
GnRH suggesting that this aspect is programmed likely
via androgenic actions of T (Manikkam et al., 2008).
Ovarian disruptions
In addition to reproductive neuroendocrine disruptions,
prenatal T treatment resulted in larger ovaries with a
multifollicular morphology (Fig. 5A) (West et al., 2001).
These effects appear not to be facilitated by the andro-
genic actions of T as prenatal DHT treatment failed to
create a multifollicular ovarian phenotype (West et al.,
2001; Steckler et al., 2007a). Detailed morphometric anal-
yses found prenatal T and DHT treatment enhanced fol-
licular recruitment with only prenatal T treatment
reducing ovarian follicular reserve to approximately 50%
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Figure 3 (A) Percentage of control (C), over-fed control (OFC), T30–90 (T) and overfed T30–90 (OFT) females that showed a luteal progesterone
increase following oestrus synchronization with prostaglandin F2a. Note that almost all of the overfed T30–90 females were anovulatory (modified
from Steckler et al., 2009). (B) Schematic showing the two-step model of programming severity of reproductive dysfunction with the first insult













Figure 4 Neuroendocrine feedback systems involved in the control of GnRH ⁄ LH secretion that are reprogrammed by prenatal T excess. GnRH ⁄ LH
release is under the control of negative feedback action of oestradiol (E) which is predominant during the pre-pubertal and anestrus period (feed-
back 1), stimulatory feedback action of E responsible for generation of the pre-ovulatory LH surge (feedback 2) and negative feedback action of
progesterone, operational during the luteal phase (feedback 3) (modified from Foster et al., 2007).
V. Padmanabhan et al. Developmental programming of adult function
ª 2010 The Authors
Journal compilation ª 2010 European Academy of Andrology • International Journal of Andrology 33 (2010), 394–404 397
2009) (Fig. 5B). Similarly, detailed daily ultrasonographic
evaluation found that follicles persist longer in prenatal
T-treated female (Manikkam et al., 2006) (Fig. 5C) and
this appears to be programmed by oestrogenic actions of
prenatal T (Steckler et al., 2007a). As such, the multifol-
licular phenotype of prenatal T females appears to be the
consequence of both enhanced follicular recruitment and
failure to regress. Immunohistochemical studies found
that prenatal T treatment increases androgen receptor
expression in the stroma and granulosa cells during foetal
life and culminates in increased granulosa cell androgen
receptor expression in antral follicles of adult females
(Ortega et al., 2009). Taken together these studies docu-
ment that excess exposure to T disrupts the ovarian tra-
jectory with some aspects programmed by androgenic
and others oestrogenic actions of T.
Metabolic dysfunctions
In addition to the neuroendocrine and ovarian disrup-
tions, prenatal T treatment leads to intrauterine growth
restriction (IUGR), low birth weight and postnatal catch-
up growth (Manikkam et al., 2004), risk factors for adult
well being (Boney et al., 2005; Dulloo, 2008). Develop-
mental changes in the insulin-like growth factor
(IGF) ⁄ IGF binding protein (IGFBP) system in the prena-
tal T-treated sheep were consistent with changes in
growth trajectory with a reduction in IGF bioavailability
evident during IUGR and an increase during postnatal
catch-up growth (Manikkam et al., 2004; Crespi et al.,
2006). Prenatal T treatment also culminated in insulin
resistance (DeHaan et al., 1990; Hansen et al., 1995; Reca-
barren et al., 2005; Padmanabhan et al., 2009) with pro-
gramming of insulin resistance facilitated via androgenic
actions of prenatal T (Padmanabhan et al., 2009). Impor-
tantly, the window of susceptibility for developing insulin
resistance was found to be confined to a shorter program-
ming window, namely 60–90 days of gestation (Padma-
nabhan et al., 2009). Recent studies assessing the impact
of prenatal T excess revealed tissue specific regulation of
members of the insulin-signalling cascade (Nada et al.,
2009). At the hepatic level, there was a general downregu-
lation of many members of the insulin signaling cascade
consistent with liver being insulin resistant. In contrast,
prenatal T excess upregulated many members of the
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Figure 5 (A) Follicular morphology of ovary
from control and T30–90 females. Note the
disrupted nature of follicular development in
T30–90 sheep (from West et al., 2001).
(B) Mean (± SEM) number of primordial and
growing follicles on foetal days 90 and 140
and 10 months of age in control (open bars),
T30–90 (closed bars) and DHT30–90 (gray
bars) ovaries (from Smith et al., 2009).
(C) Ovarian follicular dynamics determined by
ultrasonography for 8 days in both ovaries
control and T30–90 sheep during the first
breeding season (from Manikkam et al.,
2006). Each line represents only one follicle
and follicles from both ovaries are shown in
the same panel. Only follicles that reached a
size of 3 mm and persisted for at least 2 days
are shown. Note the increase in maximum
size and duration of the largest follicles on
the ovary in T30–90 sheep compared to
controls.
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supportive of increased insulin sensitivity (Nada et al.,
2009). Our unpublished observations also indicate
increased visceral adiposity in the prenatal T-treated
females. Radiotelemetric studies found that the T30–90
females are also hypertensive (King et al., 2007).
Metabolic disruptions have also been reported in other
prenatal T-treated animal models (Abbott et al., 2006;
Demissie et al., 2008).
Male reproduction
In contrast to several studies addressing the impact of pre-
natal T excess in female sheep, limited information is
available addressing the impact of prenatal T excess on
male reproduction ⁄ metabolism in sheep. Prenatal T treat-
ment increased ano-genital distance in the male offspring
compared to controls (Manikkam et al., 2004), altered the
developmental trajectory of gonadal responsiveness to
GnRH in pre-pubertal males (Recabarren et al., 2007)
and culminated in reduced sperm count and motility
(Recabarren et al., 2008). Prenatal T treatment also
increased the volume of the sexually dimorphic nucleus in
the males (Roselli et al., 2007), a complex of aromatase-
expressing neurons, whose size has been correlated with
sexual attraction in rams. Exposure to an aromatase inhib-
itor prenatally (days 50–80 of gestation) has also been cor-
related with decreased adult mounting behaviour (Roselli
et al., 2006). Information is lacking as to whether prenatal
T excess disrupts the metabolic axis in the ovine male.
Translational significance
The reproductive phenotype of T30–90 sheep parallels
features seen in women with polycystic ovarian disease
(PCOS) (Table 1). PCOS is one of the most common
reproductive disorder affecting more than 100 million
women worldwide with the economic burden exceeding
several billion dollars annually in the US. Women with
PCOS are characterized by oligo- ⁄ anovulation, hyperan-
drogenism, polycystic ovaries, LH hypersecretion and
reduced fecundity with most manifesting insulin resis-
tance (Franks, 1995). Some view PCOS as a clinical phe-
notype of the metabolic syndrome (Sam & Dunaif, 2003;
Essah & Nestler, 2006). Because the reproductive and
metabolic phenotype of prenatal T-treated sheep recapitu-
lates characteristics of women with PCOS, they provide a
valuable cost-effective resource for addressing the mecha-
nisms underlying the etiology of development of PCOS
phenotype. The constellation of reduced insulin sensitiv-
ity, hypertension and visceral adiposity found in prenatal
T treatment suggests that these animals may also be
suitable for understanding the developmental origin of
the metabolic syndrome phenotype (Mikhail, 2009).
Developmental programming by endocrine disrup-
tion chemicals
The inappropriate exposure to steroids is becoming a
major concern in the context of development of adult
pathologies. The foetus is exposed to exogenous steroids
via failed contraception, use of anabolic steroids or inad-
vertent exposure to environmental compounds with oes-
trogenic or anti-androgenic activity. Public concern has
been mounting over harmful effects of environmental
EDC, which can interfere with hormone signalling by act-
ing as agonists or antagonists (Damstra et al., 2002; Hot-
chkiss et al., 2008). Of particular concern is the
contamination of our environment and food sources with
the synthetic androgenic and oestrogenic EDCs, which
have the potential to disrupt normal androgen and
oestrogen signalling. This review focuses predominantly
on two such EDCs namely, bisphenol-A (BPA) a widely
used industrial plasticizer and methoxychlor (MXC), a
pesticide. BPA is widely used in the manufacture of epoxy
resins and polycarbonate plastics and accounts for most
oestrogenic activity in landfill leachates (Ranjit et al.,
2010; Vandenberg et al., 2009). It has been detected in
river water and sediments and more recently, in indoor
air and dust (Ranjit et al., 2010; Vandenberg et al., 2009).
MXC was used to control pests in agricultural, dairy and
domestic settings and found to persist in the environment
(National Research Council, 1999). Both these EDCs have
been shown to possess oestrogenic and anti-androgenic
properties (Staub et al., 2002; Vandenberg et al., 2009).
Targeting critical periods established by treating with
native steroids, our recent studies found that prenatal
Table 1 Characteristics of women with polycystic ovarian disease











Reduced sensitivity to steroids Yes Yes
Multifollicular ovaries Yes Yes
Increased follicular recruitment Yes Yes
Altered insulin sensitivity Yes Yes
Insulin resistance Yes Yes
Foetal growth retardation Yesa Yes
Altered behaviour Yes Yes
Hypertension Yesb Yes
Visceral adiposity Yes Yes
(observational)
Obesity amplification Yes Yes
aSpanish cohort.
bRisk factor in PCOS.
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BPA and MXC treatment had differential effects on the
reproductive axis (Savabieasfahani et al., 2006). Prenatal
BPA treatment, like prenatal T treatment, resulted in low
birth weight offspring, early hypergonadotropism and
severely dampened or absent pre-ovulatory LH surges
(Fig. 6A–C). In contrast, MXC had no effect on somatic
growth (Fig. 6A) but delayed the onset of LH surges
(Fig. 5C). The levels of BPA achieved in maternal circula-
tion following administration of 5 mg ⁄ kg body weight of
BPA (Fig. 6D) were two- to threefold higher than the
highest levels observed in the maternal circulation of US
women (Fig. 6E) (Padmanabhan et al., 2008) and other
industrialized nations (Schonfelder et al., 2002; Vanden-
berg et al., 2009). MXC levels in abdominal fat (Sava-
bieasfahani et al., 2006) were several-fold higher than that
found in human population (Botella et al., 2004). Com-
parison of reproductive defects in BPA- and MXC-treated
females with prenatal T-treated model reveal considerable
similarities between prenatal BPA- and T-treated models
(Table 2). Both groups of animals showed reduced birth
weight, LH excess and severely dampened pre-ovulatory
LH surges (Savabieasfahani et al., 2006). Others studies in
sheep found administration from days 110 to 115 of ges-
tation of octylphenol, a alkylphenol polyethoxylate used
in detergents and pesticides with oestrogenic properties,
suppressed FSH levels in both female and male offspring
(Sweeney et al., 2000). Administration of octylphenol
starting from day 70 of gestation to birth advanced the
time of puberty in female offspring (Wright et al., 2002).
Studies testing the effects of BPA and MXC in male
sheep are not available. The only available information
testing effects of EDC in male sheep comes from studies
testing the effects of octylphenol. Prenatal octylphenol
treatment from days 70 of gestation to birth reduced
testis weight and sertoli cell number in newborns
(Sweeney et al., 2000) but not semen volume ⁄ concentra-
tion and motility in adult males (Sweeney et al., 2007).
As opposed to the limited information available in sheep,
a large volume of literature already exists relative to
impact of BPA on the male offspring using rodent mod-
els. These rodent studies provide evidence that prenatal
BPA exposure leads to disruptions in the male reproduc-
tive system, which include constricted urethra and
prostate hyperplasia and cancer (Diamanti-Kandarakis
et al., 2009; Talsness et al., 2009). A recent study found

















































































Range:  <0.5 to 22.3 ng/mL
Figure 6 (A) Birth weight of control (open bars), prenatal MXC (gray
bars) and BPA-treated (closed bars) female offspring (Savabieasfahani
et al., 2006). (B) Mean circulating levels of LH in pre-pubertal control
(open bars), prenatal MXC (gray bars) and BPA-treated (closed bars)
female offspring (Savabieasfahani et al., 2006). (C) Circulating pat-
terns of LH from three control, three prenatal MXC- and three BPA-
treated females taken at 2 hourly intervals for 120 h, after induction
of luteolysis with two injections of PGF2a 11 days apart (Savabieasfah-
ani et al., 2006). (D) Levels of circulating BPA achieved in control
(open circles) and BPA-treated (closed circles) pregnant sheep on days
50, 70 and 90 of gestation (days 20, 40 and 60 of treatment) follow-
ing administration of 5 mg ⁄ kg ⁄ day administration of BPA s.c. (Sava-
bieasfahani et al., 2006). (E) Maternal levels of BPA (mean ± SEM) in
southeastern Michigan relative to maternal age (Padmanabhan et al.,
2008).
Table 2 Characteristics of prenatal testosterone (T)-, bisphenol (BPA)-







Hypergonadotropism Yes Yes No
Cycle disruption Yes Yes Yes
Dampened LH surge Yes Yes No
Increased amplitude of E2 Yes Yes No
Delayed LH surge onset Yes Yes No
Foetal growth retardation Yes Yes No
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21 reduced sperm count and motility leading to subfertili-
ty in the offspring with effects persisting in F2 and F3
generations (Salian et al., 2009). Similarly exposure to
MXC or vinclozolin during gestation resulted in reduced
spermatogenic capacity and increased incidence of male
infertility with effects transferred to subsequent genera-
tions (Anway et al., 2005).
Conclusions
Studies discussed in this review centring on sheep as a
model system enforce that the organizational programme
involved in establishing the adult phenotype is the result
of the interplay between genetic susceptibility and devel-
opmental insults (Fig. 7). These findings reinforce the
concern that inappropriate exposure to steroid hor-
mones ⁄ steroid mimics pose to the well being of the devel-
oping offspring. The pathology programmed in sheep by
BPA and MXC provides further support for the deleteri-
ous effects of EDCs on developing organ systems. Clearly,
an understanding of mechanisms underlying developmen-
tal reprogramming following exposure to EDCs is essen-
tial for developing interventions to prevent development
or reduce severity of pathology in adults. Several recent
studies point to restoration of function via methylation
by dietary supplements (Pennisi, 2005; Waterland, 2006;
Dolinoy et al., 2007; Burdge et al., 2009), providing hope
that dietary interventions may be beneficial in improving
human health. Environmental exposures are modifiable
risk factors and can be effectively regulated at the per-
sonal, behavioural as well as the regulatory policy level.
For instance, exposure to BPA through sources such as
over consumption of fast food and canned food and
overuse of baby bottles, can be addressed through public
health education campaigns and by health care providers,
including physicians, nurses, social workers and dentists.
At the policy level, environmental justice advocates can
mobilize efforts to protect poor neighbourhoods from
exposures to EDCs.
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Panel discussion
Anna-Maria Andersson (Copenhagen, Denmark)
Methoxychlor (MXC) and bisphenol A (BPA) are both oestrogenic
mimics but give different effects in your model. Can this be explained
by different mechanisms of action?
Vasantha Padmanabhan (Ann Arbor, USA)
MXC is a pesticide which has both oestrogenic and antiandrogenic
activities. BPA in addition also acts on the thyroid receptor. It has
been shown to act at the membrane level in the pancreas. The differ-
ence in effects may relate to the ratio of activation of the ERa and b
receptors, and the differential degree of antiandrogenic at the androgen
receptor (AR) level. Activation of all three receptor targets must be
considered in terms of function.
Pete Myers (Charlottesville, USA)
You recently started to use much lower doses of BPA for intrauterine
exposure, and the exposed dams were found to have hyperinsulinism.
Did this occur at both of the lower doses 0.5 and 0.05 ng ⁄ ml?
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Vasantha Padmanabhan
I presented data on low birthweight with maternal exposure to 5.0
ng ⁄ kg dose of BPA, and maternal hyperinsulinemia with the 0.5
mg ⁄ kg dose. We did not have the resources and personnel to perform
glucose tolerance tests in dams treated with other doses of BPA.
Hyunok Choi (Boston, USA)
What are the potential mechanisms by which maternal fat cells might
modify the endocrine disrupter effect during pregnancy? Please supply
references if possible. I am confused by human data whereby the effect
of xenoestrogens can be modified either by fat storage, or by endogen-
ous oestrogens being modified by vessels.
Vasantha Padmanabhan
We have not performed studies on maternal obesity. There are some
studies which show storage of BPA in fat. This would enable mobiliza-
tion during lactation, which could affect postnatal programming and
development. In the prenatal testosterone treated animals, we have
found many of the signalling pathways are affected in fetal ovaries
implicating insulin and histone proteins. Clearly epigenetic alterations
are involved. These offspring later develop visceral adiposity. The pro-
blem with sheep is that the full genome is not yet available although
the Australians are working at it. When this is available, we could per-
form an epigenetic screen to assess if epigenetic changes occur at the
level of ERa, ERb and AR.
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